Skip to main content
Newtopia Inc. logo

Newtopia Inc. — Investor Relations & Filings

Ticker · NEWU ISIN · CA6532261006 TSXV Human health and social work activities
Open in API
Filings indexed 162 across all filing types
Latest filing 2022-07-21 Regulatory Filings
Country CA Canada
Listing TSXV NEWU

About Newtopia Inc.

https://www.newtopia.com/

Newtopia Inc. operates a tech-enabled whole health platform designed to prevent, slow, and reverse chronic disease while supporting mental well-being. The platform utilizes genetic, social, and behavioral insights to deliver hyper-personalized well-being plans. Services include dedicated one-on-one guidance from health coaches, known as "Inspirators," who help participants create sustainable, positive lifelong habits. Newtopia's solutions are primarily offered to large employers and health plans, aiming to reduce organizational healthcare costs and risks through high engagement and measurable physical and emotional outcomes.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings
2022-07-21 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing two main items: a successful speaking engagement at a health insurance industry conference and the closing of a non-brokered private placement financing. It includes details about the private placement terms, related party transactions, and regulatory disclaimers about securities laws. There is no presentation of financial statements, detailed financial performance data, or management discussion of results. The document is primarily an update on financing activity and a business development event. It does not contain an earnings release, annual or interim report, or other detailed financial disclosures. Therefore, the document fits best into the category of Capital/Financing Update (CAP). The document length (over 11,000 characters) supports it being a substantive announcement rather than a brief notice or report publication announcement.
2022-06-23 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Statements' for the three months ended March 31, 2022 and 2021, indicating it is a financial report covering a quarterly period. It contains detailed financial statements including Statements of Financial Position, Loss and Comprehensive Loss, Changes in Equity, Cash Flows, and accompanying notes. The document is unaudited and prepared under IFRS IAS 34 for interim financial reporting. The length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is an annual report, audit report, or earnings release summary. The presence of comprehensive financial data and notes confirms it is an Interim / Quarterly Report (IR).
2022-05-18 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CEO of Newtopia Inc. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2022. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The document does not contain actual financial data or substantive financial analysis but is an attestation of the interim filings' accuracy and completeness. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2993 characters), and it is clearly a certification, not the report or announcement of the report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2022-05-18 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of Newtopia Inc. regarding the interim financial report and interim MD&A for the period ended March 31, 2022. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The content is primarily an officer certification attesting to the accuracy and fair presentation of the interim filings, without containing actual financial data or the interim report itself. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3005 characters), and it is clearly a certification letter, not the full interim report.
2022-05-18 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three months ended March 31, 2022, which is a detailed explanation of financial results, business trends, and outlook for a quarterly period. It includes forward-looking statements, business overview, corporate updates including financial performance, and management commentary. The document contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not an announcement or a brief summary but a comprehensive report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-05-18 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.